Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967989 · ClinicalTrials.gov registry record · Phase 3
Clarifying the Optimal Application of SLT Therapy Trial
A Phase 3 study of Glaucoma and Ocular Hypertension, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 790
- Enrollment target
- 20
- Study locations
NCT04967989 is a Phase 3 study of Glaucoma and Ocular Hypertension that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 790 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT04967989, a Phase 3 study of Glaucoma and Ocular Hypertension, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 790 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.
Conditions Studied
Interventions
- PROCEDURE Low Energy SLT
- PROCEDURE Standard Energy SLT
Study Locations (20)
California
- Harvard Eye Associates - Laguna Hills
- Doheny Eye Center UCLA - Pasadena
- University of California, Davis - Sacramento
- University of California, San Francisco - San Francisco
Illinois
- Northwestern Medical Group - Chicago
- Chicago Arbor Eye Institute - Orland Park
- Illinois Eye Center - Peoria
Massachusetts
- Massachusetts Eye and Ear - Boston
- Ophthalmic Consultants of Boston - Boston
- Mark Latina, LLC - Reading
Michigan
- University of Michigan Kellogg Eye Center - Ann Arbor
- Kresge Eye Institute Wayne State University - Detroit
Ohio
- University Hospitals Eye Institute - Cleveland
- Cleveland Clinic Cole Eye Institute - Cleveland
Colorado
- Mile High Eye Institute - Sheridan
Florida
- Clear Vue Laser Eye Center - Lakeworth
Maryland
- Wilmer Eye Institute Johns Hopkins - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 790 participants |
| Start Date | 2021-09-07 |
| Est. Completion | 2027-08-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04967989
The ClinicalTrials.gov registry entry for NCT04967989 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 790 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma and Ocular Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Low Energy SLT is the first listed.
NCT04967989 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04967989 about?
NCT04967989 is a clinical study titled "Clarifying the Optimal Application of SLT Therapy Trial". The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeatin...
What is the current status of trial NCT04967989?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 790 participants. The study started on 2021-09-07. Estimated completion is 2027-08-31.
What conditions does trial NCT04967989 study?
This clinical trial studies the following conditions: Glaucoma and Ocular Hypertension.
What interventions are being tested in trial NCT04967989?
The interventions under investigation include: Low Energy SLT (PROCEDURE), Standard Energy SLT (PROCEDURE).
Who is sponsoring clinical trial NCT04967989?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04967989 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma and Ocular Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.